Kavout
  • InvestGPT
  • Market Lens
  • Ideas Explorer
  • History
  • Blogs
  • Company
    • Portfolio Toolbox
    • Signal DB
    • About Us
  • Sign In
Select Page

TeraWulf’s 128% Gain: Can This Green Energy Bitcoin Miner Keep Up the Momentum?

Aug 12, 2024 | Stock Analysis

Key Takeaways TeraWulf has achieved a year-to-date gain of 128.75% and a market cap of $1.83 billion. The company operates with 95% zero-carbon energy, aiming for 100% sustainability. Despite impressive revenue growth, TeraWulf faces operational losses and significant...

Symbotic’s Growth and Challenges: Can This Warehouse Automation Stock Deliver Long-Term Gains?

Aug 12, 2024 | Stock Analysis

Key Takeaways Symbotic Inc. (SYM) is a leader in warehouse automation, leveraging AI-powered robotics to enhance supply chain efficiency. Despite significant revenue growth, Symbotic faces challenges with profitability and stock volatility. Recent acquisition of Veo...

Klaviyo Inc. (KVYO): A Rising Star in Marketing Tech with Strong Growth Potential

Aug 12, 2024 | Stock Analysis

Key Takeaways Klaviyo Inc. (KVYO) has shown significant revenue growth, with a 35% year-over-year increase in Q2 2024. Despite reporting a net loss, the company’s market capitalization stands at approximately $8.29 billion, reflecting strong investor confidence....

Can Affirm Navigate the BNPL Boom Amid Profitability Concerns?

Aug 12, 2024 | Stock Analysis

Key Takeaways Affirm Holdings Inc. (NASDAQ: AFRM) has shown significant growth in revenue, driven by strategic partnerships with major retailers like Apple and Amazon. Despite a substantial increase in revenue, Affirm continues to report significant net losses,...

Blackbaud (BLKB): Should Insider Selling and Valuation Concerns Worry Investors?

Aug 12, 2024 | Stock Analysis

Key Takeaways Insider Selling Activity: Significant insider selling, with no insider purchases over the past year, raises concerns about internal confidence. Valuation Metrics: Blackbaud’s high P/E ratio and fair valuation suggest potential overvaluation...

Eli Lilly’s Stock Soars: How Mounjaro and Zepbound Are Shaping Its Future

Aug 11, 2024 | Stock Analysis

Key Takeaways Eli Lilly’s Q2 2024 revenue surged by 36% year-over-year, driven by the success of Mounjaro and Zepbound. The company raised its full-year revenue guidance by $3 billion, reflecting strong market demand. Mounjaro’s sales tripled to $3.09...
Page 37 of 107« First«...102030...3536373839...506070...»Last »

Choose a Category

  • AI Chat
  • AI Stock Picker
  • Asset Selection
  • Careers
  • Coming soon
  • Company News
  • Earnings Summaries
  • Factor Investment
  • Featured Articles
  • Featured Video
  • Forecast Engine
  • General
  • Investment Ideas
  • Machine Learning
  • Pattern Recognition
  • Portfolio Models and Optimization
  • Stock Analysis

Archives

  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • January 2022
  • April 2020
  • December 2019
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • March 2018
  • January 2018
  • September 2017
  • September 2016
    KavoutLogo Header Menu
    • InvestGPT
    • Market Lens
    • Ideas Explorer
    • History
    • Blogs
    • Company
      • Portfolio Toolbox
      • Signal DB
      • About Us
    • Sign In